Zacks Investment Management’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Zacks Investment Management’s Portfolio AXLA Stock Details AXLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,165	Closed	-$50K	–	741
2023 Q1	$50K	Hold	4,165	–	–	﹤0.01%	616
2022 Q4	$34.1K	Sell	4,165 -574	-12%	-$14.9K	﹤0.01%	590
2022 Q3	$203K	Hold	4,739	–	–	﹤0.01%	543
2022 Q2	$240K	Hold	4,739	–	–	﹤0.01%	520
2022 Q1	$304K	Hold	4,739	–	–	﹤0.01%	517
2021 Q4	$248K	Hold	4,739	–	–	﹤0.01%	565
2021 Q3	$353K	Hold	4,739	–	–	0.01%	494
2021 Q2	$475K	Hold	4,739	–	–	0.01%	460
2021 Q1	$564K	Sell	4,739 -578	-11%	-$81.5K	0.01%	413
2020 Q4	$690K	Sell	5,317 -1,411	-21%	-$181K	0.01%	389
2020 Q3	$777K	Buy	+6,728	New	+$829K	0.02%	353

Other funds holding AXLA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Zacks Investment Management's AXLA Position: Q2 2023 in Review

Zacks Investment Management sold out of Axcella Health Inc. Common Stock (AXLA) in Q2 2023, closing a stake of 4,165 shares — an estimated $50K sold.

Zacks Investment Management first reported a position in AXLA in Q3 2020 and held it in 11 quarters. The position peaked at $777K in Q3 2020. 28 funds tracked by Wall St. Rank hold AXLA as of Q2 2023.

Zacks Investment Management reported no remaining Axcella Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Zacks Investment Management sold 4,165 Axcella Health Inc. Common Stock shares in Q2 2023, an estimated $50K.
Zacks Investment Management first reported a position in Axcella Health Inc. Common Stock in Q3 2020 and held it in 11 quarters.
Zacks Investment Management's Axcella Health Inc. Common Stock position peaked at $777K in Q3 2020.
28 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q2 2023.

Based on Zacks Investment Management's 13F filing for Q2 2023, filed 15 Aug 2023.